| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia
|
Ampatzidou, Mirella
|
|
2017
|
11 |
1 |
p. 47-53
|
artikel
|
| 2 |
Anti-angiogenic therapies in brain metastases
|
Berghoff, Anna S.
|
|
2018
|
11 |
1 |
p. 14-17
|
artikel
|
| 3 |
Antiangiogenic therapies in ovarian cancer
|
Vanderstichele, Adriaan
|
|
2018
|
11 |
1 |
p. 18-26
|
artikel
|
| 4 |
Cell free nucleic acids as diagnostic and prognostic marker in leukemia
|
Eini, Maryam
|
|
2017
|
11 |
1 |
p. 65-70
|
artikel
|
| 5 |
Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017
|
|
|
2018
|
11 |
1 |
p. 80
|
artikel
|
| 6 |
ESMO 2017—my personal highlights
|
Kiesewetter, Barbara
|
|
2018
|
11 |
1 |
p. 77-79
|
artikel
|
| 7 |
In need of special care: adolescent and young adult patients with cancer
|
Dworzak, Michael N.
|
|
2018
|
11 |
1 |
p. 5-6
|
artikel
|
| 8 |
Local therapy of stage IV renal cell cancer: a case report
|
Ferner, Muna
|
|
2018
|
11 |
1 |
p. 38-42
|
artikel
|
| 9 |
memo—publisher’s report 2017
|
Sillaber, Alois
|
|
2018
|
11 |
1 |
p. 7-8
|
artikel
|
| 10 |
My burning issues in the neoadjuvant treatment for breast cancer
|
Bergen, Elisabeth S.
|
|
2017
|
11 |
1 |
p. 27-30
|
artikel
|
| 11 |
My burning issues in TKI therapy and treatment-free remission in CML
|
Wolf, Dominik
|
|
2017
|
11 |
1 |
p. 31-32
|
artikel
|
| 12 |
Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood
|
Bardi, Edit
|
|
2018
|
11 |
1 |
p. 54-58
|
artikel
|
| 13 |
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients
|
Resch, Irene
|
|
2018
|
11 |
1 |
p. 43-46
|
artikel
|
| 14 |
Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity
|
Ghannam, Malik
|
|
2018
|
11 |
1 |
p. 71-76
|
artikel
|
| 15 |
Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer
|
Horak, Peter
|
|
2018
|
11 |
1 |
p. 33-37
|
artikel
|
| 16 |
Revival of anti-angiogenic therapies in cancer
|
Pircher, Andreas
|
|
2018
|
11 |
1 |
p. 1-2
|
artikel
|
| 17 |
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
|
Willenbacher, Ella
|
|
2018
|
11 |
1 |
p. 59-64
|
artikel
|
| 18 |
Targeting angiogenesis in lung cancer
|
Daher, Sameh
|
|
2018
|
11 |
1 |
p. 9-13
|
artikel
|
| 19 |
Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes
|
Vogl, Ursula M.
|
|
2018
|
11 |
1 |
p. 3-4
|
artikel
|
Tijdschrift beschrijving